ЛИТЕРАТУРА

1. Актуальные вопросы урогенитальных инфекций // Учебно-методическое пособие. - Смоленск: СГМА, 2003. - 71 с.

2. Анемии беременных и новорожденных // Учебно-методическое пособие.

3. Антибактериальная терапия инфекций мочевыводящих путей у беременных. Пособие для врачей. И Клиническая микробиология и антимикробная химиотерапия. - 2004. - т. 6. - № 2. - С. 218-223.

4. Арбатская Н.1О. Йод-дефицитные заболевания и беременность: профилактика, диагностика и лечение И Р.М.Ж. - 2004. - т.12. - № 13. - С. 14-16.

5. Вихляева Е.М, Супряга О.М. Проблемы ОПГ-гестозов // М.: Медицина, - 1996.

6. Вихляева Е.М. Медикаментозная профилактика осложнений гестационного процесса И Тер. архив - 1999. - Л»10. - С.49-53.

7. Власов В.В. Введение в доказательную медицину - М.: Медиасфера, 2001.-392 с.

8. Гуревич К.Г. Побочные эффекты лекарственных веществ растительного происхождения // Кач. клин, практика - 2003. - .V° 1. - С. 71-74.

9. Диагностика, лечение и профилактика внутриутробных инфекционных заболеваний //Учебно-методическое пособие. - Смоленск: СГМА, 2003. -103 с.

10. Доказательная медицина. Ежегодный справочник. Часть 4. Пер. с англ. - Под ред. Баїцинского С.Е. - М.: Медиа Сфера, 2003. - 162 с.

11. Задержка внутриутробного развития плода // Учебно-методическое пособие. - Смоленск: СГМА, 2001. —46 с.

Карпов О. И., Зайцев Л. А. Риск применения лекарств при беременности и лактации - С.-Петербург: БХВ, 1998. - 352 с.

Касабулатов Н.М. Плацентарная недостаточность // Р.М.Ж. - 2004. - т.12.-№ 13.-С. 28-30.

Кирющснков /\.П., Тараховский МЛ. Влияние лекарственных средств на плод. - М.: Медицина, - 1990. - 216 с.

Клинико-организационное руководство для лечения женщин с гипертензией, вызванной беременностью // Комитет по здравоохранению Российско-Американскоой Межправительственной комиссии по экономическому и технологическому сотрудничеству.

2001.-29 с.

Коденцова В.М., Вржесинская О.А. Витамины в питании беременных // Гинекология. - 2002. - т.4. - №1. - С. 7-12.

Коноводова Е.Н. Диагностика и принципы лечения железодефицитных состояний у беременных // Гинекология. - 2003. т.5. - №6. - С. 258-260. Кыомерле Х.П., Брендел К. Клиническая фармакология при беременности. В 2-х томах. Пер. с англ. - М.: Медицина, - 1987. Лекарственные средства, применяемые в акушерстве и гинекологии // Под рсд. Кулакова В.И., Серова В.Н., Барашнева Ю.И. - М.: ГЭОТАР- МЕД, 2004. - 320 с.

Невынашивание беременности // Учебно-методическое пособие. - Москва: РМАПО М3 РФ, 2004. - 32 с.

Орджоникидзе Н. В., Клименко П. А., Дживигелова Г. Д. и др. Новое в лечении беременных с синдромом задержки развития плода // Акушерство и гинекология. - 1996. - № 3. - С. 32-36.

Орджоникидзе Н.В. Вульвовагинальный кандидоз в акушерской практике// Гинекология. - 2004. - т.6. - №4. - С. 189-191.

Приказ № 323 Минздрава РФ «Об отраслевых стандартах объёмов акушерско—гинекологической помощи» от 05.11.1998.

Приказ № 50 Минздрава РФ «О совершенствовании акушерско - гинекологической помощи в амбулаторно - поликлинических учреждениях» от 10.02 2003.

Профилактика и лечение плацентарной недостаточности // Учебно- методическое пособие - Санкт-Петербург: НИИ акушерства и гинекологии им. Д.О. Оіта РАМН, - СГІГУ.

Радзинский B.R. Фармакотерапия плацентарной недостаточности. // Клин. фарм. и тер. - 1998.- Ле 3 - С. 91 - 96.

Резников А.Г. Прогестагены, беременность и здоровье плода И Гинекология. - 2003. - № 6. - том 5. - С.260-262.

Руководство по безопасному материнству // Под рсд. Кулакова В.И., Серова В.Н. - Москва: Триада X. - 1998. - 596 с.

Серов В.Н. Диагностика и терапия плацентарной недостаточности И РМЖ. - 2002. - т.10. - №7. - С. 40-44.

Серов В.Н., Стрижаков Л.Н., Маркин С.Л. Руководство по практическому акушерству. - М.: Медицинское информационное агенство, - 1997,- 424 с.

Сидельникова В.М. Актуальные проблемы невынашивания

беременности - М.,1999.

Современные аспекты диагностики, терапии, профилактики и реабилитации гестоза // Методическое пособие. - Смоленск: СГМА,

2003. - 66 с.

Страчунский Л.С., Белоусов Ю.Б., Козлова С.Н. Практическое руководство по антииифекционной химиотерапии - М.: Боргес, - 2002. - 384 с.

Страчунский Л.С., Козлов С.Н., Рачина С.А. Фармакоэпидемиология: основные понятия и практическое применение // Клин. фарм. и тер. - 2001.-№4-С. 48- 53.

Супряга О. М. Лекарственная терапия артериальной гипертонии у беременных в лечебных учреждениях России (популяционное исследование) // Тер. архив - 1999. - №10. С. 57-61.

Федеральное руководство по использованию лекарственных средств (формулярная система). Выпуск V. - М.: ЭХО, 2004. - 944 с.

Флетчер Р., Флетчер С., Вагнер Е. Клиническая эпидемиология. Основы доказательной медицины. 3-є изд. Пер. с англ. - Под ред. Бащинского С.Е., Варшавского С.Ю. - М.: Медиа Сфера. - 1998. - 352 с.

Четли Э. Проблемные лекарства. - Riga, Latvia.: Health Action International, 1998. - 352 c.

Шехтман M.M. Железодефицнтная анемия и беременность // Гинекология - 2004. -№ 4. - том 6. - С.204-210.

Шехтман М.М. Руководство по экстрагенитальной патологии у беременных. - М.: Медицина, 2003. - 815 с.

Abalos Е., Duley L., Steyn D.W., Henderson-Smart D.J. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. In: The Cochrane Library, Issue 4, 2001. Oxford: Update Software. Primary sources Cochrane Pregnancy and Childbirth group trials register, Cochran Controlled trials register, Medline, Embasc.

Abdul I-Iadi В., Torok J., Mezey G. Drug utilization study during pregnancy // Acta Pharm. Hung. - 1995. - Vol. 65. - № 3. - P. 69-75.

Addis A., Magrini N., Mastroiacovo P. Drug use during pregnancy // Lancet. - 2001.-Vol. 357.-P. 800.

Addis A., Sharabi S., Bonati M. Risk classification system for drug use during pregnancy: are they a reliable source of information? // Drug Saf. - 2000. Vol. 23.-P. 245-253.

Alejandro A, Koren G. Multivitamin supplements for pregnant women // Motherisk Update. - 2004. - available at http://www.motherisk.org.

American College of Obstetricians and Gynecologists (ACOG). Intrauterine growth restriction // ACOG prac. bulletin № 12. - Washington (DC): ACOG, 2000.- 12 p.

American College of Obstetricians and Gynecologists: Antimicrobal therapy for obstetrics patients // ACOG educ. bulletin № 245. - Washington (DC): ACOG, 1998.

American College of Obstetricians and Gynecologists: Hypertension in pregnancy // ACOG tcchn. bulletin № 219. - Washington (DC): ACOG, 1996. American College of Obstetricians and Gynecologists: Management of pretenn labor И ACOG prac. bulletin № 43. - Washington (DC): ACOG,

2003. - 9 p.

American College of Obstetricians and Gynecologists: Nausea and vomiting of pregnancy // ACOG prac. bulletin № 52. - Washington (DC): ACOG,

2004.

Andrade S.E., Gurwitz J.I I., Davis R.L., Chan K.A., et al. Prescription drug use in pregnancy // Am. J. Obstct. Gynecol. - 2004. - Vol. 191. - P. 398-407.

Arsenault M.Y., Lane C.A. The managmant of nausea and vomiting of pregnancy // J. Obstet. Gynecol. Can. - 2002. - Vol. 24. - P. 817-823.

Beard J.L. Effectiveness and strategies of iron supplementation during pregnancy .7 Am. J. of Clin. Nutr. - 2000. - Vol. 71. - №. 5. - P. 1288-1294. Beaton G.H. Iron needs during pregnancy: do we need to rethink our targets? // Am. J. Clin. Nutr. - 2000. - Vol. 72. - P. 265-271.

Bernstein 1., Gabbe S.G. Intrauterine growth restriction. In: Gabbe S.G., Niebyl J.R., ct al., eds. Obstetrics: normal and problem pregnancies: 3d ed. - New York: Churchill Livingstone, 1996. - P. 863-886.

Beyens N., Guy C., Ratrema M., Ollagnier M. Prescription of Drugs to Pregnant Women in Prance: the HIMAGE Study // Therapie - 2003. - Vol. - 58.-P. 505-511.

Bianca S. Drug use during pregnancy: are risk classifications more dangerous than the dnigs? // Lancet. - 2003. - Vol. 362. - P. 329.

Black R.A., Hill D.A. Over - the counter medications in pregnancy // Am. Fam. Phys. - 2003. - Vol. 67. - P. 2517-2524.

Bombardier C. Research challenges; overview of epidemiological study design // J Rheumatol. - 1998. - Vol. 15 (Suppl. 17). - P. 5-8.

Bonati M, Borlolus R, Marchctli F, Romero M, Tognoni G. Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. // Eur. J. Clin. Pharmacol. - 1990. - Vol. - 38. - P.:325-328.

Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in Pregnancy and Lactation. - Philadelphia: Lippincott Williams & Wilkins, 6th Ed, 2002.

Brocklehurst P, Rooney G. Interventions for treating genital chlamydia trachomatis infection in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.

C.L.A.S.P. (Collaborative Low-dose Aspirine Study in Pregnancy) Collaborative Group. C.L./VS.P.: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant woman // Lancet. - 1994. Vol. 343. - P. 619-629.

Carey J.C., Klebanoff M.A. Bacterial Vaginosis and Other Asymptomatic Vaginal Infections in Pregnancy // Current Women's Health Reports. - 2001. -Vol. l.-P. 14-19.

Centers for disease control and prevention. Sexually transmitted diseases treatment guidelines 2002 // MMWR. - 2002. - Vol. 51. - > RR-6. - 84 p. Chappell L.C., Seed P.T., Briley A.L., et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial // Lancet. - 1999. - Vol. 354. - P. 810-816.

Child TJ. Management of hyperemesis in pregnant women // Lancet. - 1999.

- Vol. 353.-P. 325-329.

Christensen B. Which antibiotics arc appropriate for treating bacteriuria in pregnancy? // J. of Antimic. Chcmoter. - 2000. - Vol. 46. - P. 29-34.

Churchill D., Bayliss H., Beevcrs G. Fetal growth restriction // Lancet. - 1999. - Vol. 355. - P. 1366-1367.

Collaborative Group on Drug Use in Pregnancy (C.G.D.U.P.): Medication during pregnancy: an intercontinental cooperative study // Int.

Crowley P.A. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994 // Am. J. Obstet. Gynecol. - 1995/ - Vol. 173.

- P. 322-335.

Cuervo L.G., Mahomed К. Treatments for iron deficiency anaemia in pregnancy (Cochrane Review) // In: The Cochrane Library, Issue 4, 2004. - Chichester, UK: John Wiley & Sons, Ltd.

Czeizel A.E. Folic acid in the prevention of neural tube defects // J. Pediatr. Gastroenterol. Nutr. - 1995. - Vol. 20. P. 4—16.

Czeizel A.E., Rockenbauer M., Olsen J. Use of antibiotics during pregnancy. Eur. J. of Obstet. Gynecol. Reprod. Biol. - 1998. Vol. - 81. - P. 1-8.

Czeizel, A. E., Dudas, 1. and Metneki, J. Pregnancy outcomes in a randoinizcd-controlled trial of pcriconceptional multivitamin supplementation. Il Archives of Gynecology and Obstetrics. - 1994. - Vol. 255.-P. 131-139.

De Vigan C., De Wallc H.E., Cordier S., Goujard J., Knill-Jones R., Ayme S., Calzolari E., Bianchi F. Therapeutic drug use during pregnancy: a comparison in four European countries. OECM Working Group // J. Clin. Epidemiol. 1999,-Vol. -52.-P. 977-982.

De Jong-van den Berg L., Van den Berg P.B., Haaijer-Ruskamp FM, et al. Investigating drug use in pregnancy: methodological problems and perspectives // Pharm. Weekbl. Sci. - 1991. - Vol. 13. - P. 32-38.

Dclzell, J.E., Lefevre M.L. Urinary Tract Infections During Pregnancy // Am. Fam. Phys. - 2000. - Vol. 61. - P.713-721.

Dickson M.J. Management of hyperemesis in pregnant women // Lancet. - 1999. - Vol. 353. - P. 325-330.

Donati S., Baglio G., Spinelli A., Grandolfo M.E. Drug use in pregnancy among Italian women // Eur. J. Clin. Pharmacol. - 2000. - Vol. 56. - № 4. - P. 323-328.

Duley L., Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia. In: The Cochrane Library, Issue 4, 2001. Oxford: Update Software. Primary source Cochrane Pregnancy and Childbirth group trials register.

Duley L., Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. In: The Cochrane Library, Issue 4, 2001. Oxford: Update Software. Primary source Cochrane Pregnancy and Childbirth group trials register.

Egen V., Hasford J. Drug utilization in pregnancy - final report of the prospective study «PEGASUS» // Pharmacoep. and Drug Saf. - 2002. - Vol. ll.-P. 29.

Einarson T.R., Bergman U., Wiholm B.E. Principles and practice of pharmacoepidemiology // Avery’s Drug Treatment / Ed. Speight T.M., Holford N.H.G. - New- Zealand: Adis International Limited; 1997. - P. 371- 392.

Fetal growth restriction. In: Cunningham F.G., et al., eds. Williams Obstetrics: 20th ed. - Stamford Conn.: Appleton & Lange, 1997. - P. 839- 854.

Goldenberg R.L. The management of preterm labor // Obstet. Gynecol. - 2002.-Vol. 100.-P. 1020-1037.

Giilmezoglu AM. Interventions for trichomoniasis in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.

Gulmezoglu M., de Onis M., Villar J. Effectiveness of interventions to prevent or treat impaired fetal growth // Obstet. Gynecol. Surv. - 1997. - Vol. 52.-P. 139-149.

Haram К., Nilsen S.T., Ulvik R.J. Iron supplementation in pregnancy — evidence and controversies // Acta Obstet. Gynecol. Scand. - 2001. - Vol. 80. - P. 683—688.

Haramburu F., Miremont G., Moore N. Good and bad drug prescribing in pregnancy И Lancet. - 2000. - Vol. 356. - P. 1704.

Haramburu F., Miremont G., Moride Y., et. al. Drug prescription during pregnancy: a cohort study // Pharmacocp. Drug Saf. - 1995. - Vol. 4. - C. 74. Hartzema A.G. Pharmacoepidemiology - its relevance to clinical practice // J Clin Pharm and Therapeutics. - 1992. - Vol. 17. - P. 73-74/

Hartzema A.G. Pharmacoepidemiology - its relevance to clinical practice // J Clin Phann and Therapeutics. - 1992. - Vol. 17. - P. 73-74.

Hartzema A.G., Porta M.S., Tilson H.H. Introduction to pharmacoepidemiology // Drug Intell Clin Pharm. - 1987. - Vol. 21. - P. 739- 740.

Hartzema A.G., Porta M.S., Tilson H.H. Pharmacoepidemiology: an introduction. - Cincinnati: Harvey Whitney Books, 1991. - 448 p.

Headley J., Northstonel K., Simmons 1 H., Golding J. Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children// Eur. J. Clin. Pharmacol. - 2004. - Vol. 60. - № 5. - P. 355.

Hcikkila A.M., Erkkola R.U., Nummi S.E. Use of medication during pregnancy - a prospective cohort study on use and policy of prescribing // Ann. Chir. Gynaecol. - 1994. - Vol. 208. - P. 80-83.

Hennessy S. Postmarketing drug surveillance: an epidemiologic approach // Clinical Therapeutics - 1998. - Suppl. 20. - P. 32-39.

99. Henry A., Crowther C. Patterns of medication use during and prior to pregnancy: the MAP study // Aust. N. Z. J. Obstet. Gynaecol. - 2000. - Vol. 40.-P. 165-172.

100. Herbst A.L., Ulfelder H., Poskanzer D.C. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women // New Engl J M. - 1971. - Vol. 284. - P. 878-881.

101. Hopkins L, Smaill F. Antibiotic regimens for management of intraamniotic infection (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.

102. Jewell D., Young G. Interventions for nausea and vomiting in early pregnancy (Cochrane Review) // The Cochrane Library, Issue 4, 2004. - Chichester, UK: John Wiley and Sons, Ltd.

103. Jick I I., Rodriguez L.A.G., Percz-Gutthann S. Principles of epidemiological research on adverse and beneficial drug effects // Lancet. - 1998. - Vol. 352. - P. 1767-1770.

104. Kapur B., Soldin O.P., Koren G. Potential prevention of neural tube defects by assessment of women of childbearing age through monitoring of folate // Ther. Drug Monit. - 2002. - Vol. 24. - P. 628-630.

105. Koren G., Boskovic R., Hard M., Maltcpe C., Navioz Y., Einarson A. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy // Am. J. Obstet. Gynecol. -2002. - Vol. 186. - P. 228-231.

106. Koren G., Pastuszak A., Ito S. Drugs in Pregnancy //N. Engl. J. Med. - 1998. - Vol. 338,-P. 1128-1137.

107. Lacroix 1., Damase-Michel C., Lapeyre-Mestre M., Montastruc J.L. Prescription of drugs during pregnancy in France // Lancet. - 2000. - Vol. - 356.-P. 1735-1736.

108. Ladipo О.Л. Nutrition in pregnancy: mineral and vitamin supplements // Am. J. Clin. Nutr. - 2000. - Vol. 72. - P. 280-290.

109. Larimore W.L., Petrie K.A. Drug use during pregnancy and lactation // Primary Care, Clinics in Office Practice. - 2000. - Vol. 27. - P. 314-335.

110. Lazarou J., Pomeranz B., Corey P. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies // JAMA. - 1998. -Vol. 279.-P. 1200-1205.

111. Lee D., Bergman U. Studies of drug utilization. In: Strom B.L., editor. Pharmacoepidemiology. 2nd ed. New York: John Wiley & Sons, Inc.; 1994. p. 379-395.

112. Lee J.A.II., Draper P.A., Weatherall M. Prescribing in three English towns // Milbank Mem Fund Q. - 1965. - Vol. 43. - P. 285-290.

113. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.

114. Macones G.A., Sehdev H.M., Berlin M., et al: Evidence for magnesium sulfate as a tocolytic agent // Obstet. Gynecol. Surv. - 1997. - Vol. 52. - P. 652-658.

115. Mahomed K. Folate supplementation in pregnancy (Cochrane Review) // In: The Cochrane Library. - Issue 4. - 2004. - Chichester, UK: John Wiley & Sons, Ltd.

116. Makrides M., Crowther C.A. Magnesium supplementation in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.

117. Malm 1-І., Martikaincn J., Klaukka T., Neuvoncn P.J. Prescription drugs during pregnancy and lactation - a Finnish register-based study // Eur. J. Clin. Pharmacol. - 2003. - Vol. 59. - № 2. - P. 127-133.

118. Marzctti L., Boni T., Fazzio M., Giobbe M. Current role of progesterone therapy in (he prevention of spontaneous abortion and in the treatment of threatened abortion // Minerva Ginecol. - 2000. - Vol. - 52. - P. 515-519.

119. Mazzotta P., Magee L.A. A risk-benefit assessment of pharmacological and nonphannacological treatments for nausea and vomiting of pregnancy // Drugs. - 2000. - Vol. 59. P. 781-800.

120. McBride W.G. Thalidomide and congenital abnormalities // Lancet. - 1961. - Vol.2.-P. 1358.]

121. McDonald H, Brocklehurst P, Parsons J, Vigneswaran R. Antibiotics for treating bacterial vaginosis in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.

122. McElhatton P.R. General principles of drug use in pregnancy // The Pharmaceut. J. - 2003. - Vol. 270. - P. 232-234.

123. Menguea S.S., Schcnkellb E.P. Drug use by pregnant women in six Brazilian cities. // Rev. Saude Publica. - 2001. - Vol. - 35. — P. 46-49.

124. Moudgal V.V., Sobel J.D. Antifungal drugs in pregnancy: a review // Expert Opin. Drug Saf. - 2003. - Vol. 2. - P. 475-483.

125. MRS Vitamin Study Research Group. Prevention of neural tube defects: Research Council Vitamin Study// Lancet. - 1991. - Vol. 338. - P. 131-137.

126. Nageotte M.P., Briggs G.G., Towers C.V., Asrat T. Droperidol and diphenhydramine in the management of hyperemesis gravidarum H Am. J. Obstet. Gynecol. 1996.-Vol. 174/-P. 1801-1805.

127. National Heart Lung and Blood Institute. National High Blood Pressure Education Program: Working Group Report on High Blood Pressure in Pregnancy // Bethesda (MD): National Heart, Lung and Blood Institute (NI-ILBI). - 2000. - 38 p.

128. Nordcng H., Eskild A., Nesheim B., Jacobson G. Drug use in pregnancy among parous Scandinavian women // Norw. J. of Epidemiol. - 2001. - Vol. ll.-P. 97-103.

129. Olesen C., Sondergaard C., Thranc N., de Jong-van den Berg L; Olsen J. for the EuroMAP Group Do Pregnant Women Report Use of Dispensed Medications? // Epidemiology. - 2001. - Vol. 12. - P. 497-501.

130. Olesen C., Sorensen H.T., de Jong-van den Berg L., Olsen J., Steffensen F.I I. Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. The Euromap Group // Acta Obstet. Gynecol. Scand. - 1999. - Vol. 78. - P. 686- 692.

131. Paulus W.E. Pharmacotherapy in pregnancy // Ther L'msch. - 1999. - Vol. 56. - P. 602-607.

132. Physicians’ Desk Referens, 2003 // Montvale, N.J.: Medical Economics Co Inc, - 2003.

133. Piercy N.C. Treatment of nausea and vomiting in pregnancy. When should it be treated and what can be safely taken? // Drug. Saf. - 1998. - Vol. 19. - P. 155-164.

134. Pinilla R.E., Frias M. Corticosteroids during pregnancy and oral clefts: a case- control study // Teratology. - 1998. - Vol. 58. - P. 2-5.

135. Piper J.M., Baum C., Kennedy D.L: Prescription drug use before and during pregnancy in a Medicaid population // Am. J. Obstet. Gynecol. - 1987. - Vol. 157.-P. 148-156.

136. Powrie R.O., Kuri R. Prescribing drugs to pregnant women // Women’s Health in Primary Cary. 1999. - Vol. 2. - P. 547-554.

137. Prevention and control of deficiency anaemia in women and children // Report of the UNICEF/WHO regional consultation. - 1999. - 119 p.

138. Quinland J.D., Hill D.A. Nausea and Vomiting of Pregnancy // Am. Fam. Physician. - 2003. - Vol. 68. - № 1. -P. 261-273.

139. Rayncs-Grcenow CH, Roberts CL, Bell JC, Peat B, Gilbert GL. Antibiotics for ureaplasma in the vagina in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.

140. Redman C.W., Roberts J.M. Management of pre-eclampsia // Lancet. - 1993. - Vol.41.-P. 1451-1454.

141. Reprotox database. - available at http://www.reprotox.org

142. Rizk M.A., Abdel-Aziz F., Ashmawy A.A., Mahmoud A.A., Abuzeid T.M. Knowledge and practices of pregnant women in relation to the intake of drugs during pregnancy // J. Egypt. Public. Health. Assoc. - 1993. - Vol. 68. - P. 567-591.

143. Roberts J.M., Redman CAV.G. Pre-eclampcia: more than pregnancy-induced hypertension// Lancet. - 1993. - Vol. 341. - P. 1447-1451.

144. Robinson M.J., Pash J., Grimwade J., Campbell J. Fetal warfarin syndrome // Med J Aust. - 1978.-Vol. l.-P. 157.

145. Ronning M. Setting-up the WHO АТС classification of drugs and the Defined Daily Dose - problems and potential for standardizing drug use research worldwide. In: McGavock II., editor. Handbook of Drug Use Research Methodology. 1st ed. Newcastle: The United Kingdom Drug Utilization Research Group; 2000. p. 1-9.

146. Rubin J.I)., Ferencz C., Loffrcdo C., et al. Use of prescription and non- prescription drugs in pregnancy // J. Clin. Epidemiol. - 1993. - Vol. 46. - P. 581-589.

147. Rubin P.C. Drug treatment during pregnancy // B.M.J. - 1998. - Vol. 317. - P. 1503-1506.

148. Rubin P.C., Rutherford J.M. Drug therapy in pregnant and breastfeeding women. - Clinical Pharmacology // New York: Melmon & Morellis, 2000. - P. 1117-1141.

149. Rust O.A., Bofill J.A., Arriola R.M., et al: The clinical efficacy of oral tocolytic therapy // Am. J. Obstet. Gynecol. - 1996. - Vol. 175. - P. 838-842.

150. Schirm E., Willemijn M.M., Hikle T., de Jong-van den Berg L. Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system // Eur J Obstct. Gynecol. Reprod. Biol. - 2004. • Vol. 114. - P. 182-188.

151. Scheinfeld N. S., Davis A. Teratology and drug use During Pregnancy // www.emedicine.com. 2005, March 17.

152. Shehata H.A., Nelson-Piercy C. Drugs to avoid // Best Prac. & Res. Clin. Obstet. And Gynecol. - 2001. - Vol. 15. - №6. - P. 971-986.

153. Sibai B.M. Treatment of hypertension in pregnant women // N. Engl. J. Med. - 1996. - Vol. 335. - P. 257-265.

154. Sotiriadis et al. Threatened miscarriage: evaluation and management // B.M.J.

- 2004. - Vol. 329. - P. 152-155.

155. Spitzer W.O., Lewis M.A., Heincmann L.A.J., e.a. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study // BMJ. — 1996. - Vol. 312. — P. 83-88.

156. Splinter M.Y., Sagraves R., Nightengale B., Rayburn W. F. Prenatal use of medications by women giving birth at a university hospital // Southern Medical J. - 1997. - Vol. 90. - P. 498-502.

157. Spading L., Spatling G. Magnesium supplementation in pregnancy: a double

- blind study // Br J Obstet Gynaecol. - 1998. Vol. 95. - P. 120-125.

158. Strom B.L. Study designs available for pharmacoepidemiology studies // Pharmacoepidemiology / Ed. Strom B.L. - New York: John Wiley & Sons, Inc., 1994.-P. 15-29.

159. Strom B.L. What is pharmacoepidemiology? // Pharmacoepidemiology / Ed. Strom B.L. - New York: John Wiley & Sons, Inc.; 1994. - P. 3-15.

160. Strom B.L. When should one perform pharmacoepidemiology studies? // Pharmacoepidemiology / Ed. Strom B.L. - New York: John Wiley & Sons, Inc.; 1994.-P. 57-69.

161. The investigation and management of the small-for-gcstational-age fetus. Royal College of Obstetricians and Gynecologists // Guideline №31.- 2002.

- 16 p.

162. Thinkhamrop J, Hofmcyr GJ, Adetoro O, Lumbiganon P. Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.

163. Thurmann P.A., Steioff A. Drug treatment in pregnancy // Int. J. Clin. Pharmacol. Ther. - 2001. - Vol. 39. - P. 185-191.

164. Van Boxtel C.J. Wang G. Some observations on pharmacoepidemiology in Europe // Ncthelands J Med. - 1997. - Vol. 51. - P. 205-202.

165. Vazquez. J.C., Villar J. Treatments for symptomatic urinary tract infections during pregnancy (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.

166. Webster W.S., Freeman J.A. Prescription drugs and pregnancy // Expert Opin. Pharmacother. - 2003. - Vol. 4. - P. 949-961.

167. Whitehead R.M., Haas D.M., Carrier J.A. Progestogen for preventing miscarriage (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.

168. Wilson-Davis K. Study design and the use of statistics in drug use research // Handbook of Drug Use Research Methodology / Ed. McGavock H. - Newcastle: The United Kingdom Drug Utilization Research Group, 2000. - P. 36-55.

169. World Health Organization (1997) Managemaht of low-and high-risk pregnancies // WI IO Regional Office for Europe.

170. Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy (Cochrane Review). In: The Cochrane Library-, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.